iRhythm Technologies, Inc.·4

Jan 17, 5:25 PM ET

Garrett Matthew C. 4

4 · iRhythm Technologies, Inc. · Filed Jan 17, 2020

Insider Transaction Report

Form 4
Period: 2020-01-15
Garrett Matthew C.
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2020-01-15$8.18/sh+7,684$62,85528,551 total
  • Sale

    Common Stock

    2020-01-15$80.00/sh21,013$1,681,04020,867 total
  • Exercise/Conversion

    Common Stock

    2020-01-15$17.00/sh+21,013$357,22149,564 total
  • Sale

    Common Stock

    2020-01-15$80.00/sh7,684$614,72041,880 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2020-01-157,6845,424 total
    Exercise: $8.18Exp: 2025-12-15Common Stock (7,684 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2020-01-1521,0139,585 total
    Exercise: $17.00Exp: 2026-10-19Common Stock (21,013 underlying)
Footnotes (3)
  • [F1]The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2019
  • [F2]All of the shares subject to this option are fully vested and exercisable as of the date hereof.
  • [F3]The option, originally granted for 30,598 shares, of which 21,013 shares have been exercised, vested as to 1/4 of the shares on September 21, 2017 and as to 1/36 of the remaining shares each month thereafter.

Documents

1 file
  • 4
    wf-form4_157929989070440.xmlPrimary

    FORM 4